PARIS study group

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients”.

Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients

EBioMedicine(2021)10.1016/j.ebiom.2021.103626

N/A

0DataRank · unranked

55 citations

Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat, Angela A. Amoako +10 more

Efficient mucosal antibody response to SARS-CoV-2 vaccination is induced in previously infected individuals

medRxiv(2021)10.1101/2021.12.06.21267352

N/A

0DataRank · unranked

23 citations

Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason +5 more

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37

medRxiv(2021)10.1101/2021.07.21.21260961

N/A

0DataRank · unranked

18 citations

Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat, Angela A. Amoako +36 more

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

Nature Communications(2022)10.1038/s41467-022-32389-8

N/A

0DataRank · unranked

168 citations

Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason +25 more

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

medRxiv(2022)10.1101/2022.04.15.22273914

N/A

0DataRank · unranked

6 citations

Gagandeep Singh, Johnstone Tcheou, Komal Srivastava, Charles Gleason, Hiromi Muramatsu +8 more

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection

mBio(2023)10.1128/mbio.02280-23

N/A

0DataRank · unranked

21 citations

Gagandeep Singh, Kaori Sano, Charles Gleason, Komal Srivastava, PARIS study group +24 more

The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera

mBio(2023)10.1128/mbio.02250-23

N/A

0DataRank · unranked

15 citations

Anass Abbad, Giulio Kleiner, Komal Srivastava, Charles Gleason, PARIS study group +22 more

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.24.554732

N/A

0DataRank · unranked

4 citations

Gagandeep Singh, Kaori Sano, Charles Gleason, Komal Srivastava, PARIS study group +4 more

The post-COVID-19 population has a high prevalence of crossreactive antibodies to spikes from all Orthocoronavirinae genera

medRxiv(2023)10.1101/2023.08.01.23293522

N/A

0DataRank · unranked

3 citations

Anass Abbad, Giulio Kleiner, Komal Srivastava, Charles Gleason, PARIS study group +4 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023

medRxiv(2023)10.1101/2023.12.18.23300131

N/A

0DataRank · unranked

2 citations

Abram L. Wagner, Brian Monahan, Daniel Floda, Ana S. Gonzalez‐Reiche, Johnstone Tcheou +14 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023

Nature Communications(2024)10.1038/s41467-024-50052-2

N/A

0DataRank · unranked

17 citations

Abram L. Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana S. Gonzalez‐Reiche +27 more